![Frank Pompilio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank Pompilio
Nessuna posizione attualmente
Profilo
Frank Pompilio worked as a Senior Director-Medical Affairs at Kythera Biopharmaceuticals LLC from 2014 to 2016.
He then served as Vice President-Medical Affairs at MannKind Corp.
from 2016 to 2019.
Prior to his industry roles, he was an Assistant Professor-Pharmacy at the University of Southern California.
Currently, he holds the position of Vice President-Medical Affairs at Arcutis Biotherapeutics, Inc. Dr. Pompilio holds a doctorate degree from the University of Southern California and an undergraduate degree from the University of California, Santa Barbara.
Precedenti posizioni note di Frank Pompilio
Società | Posizione | Fine |
---|---|---|
MANNKIND CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/10/2019 |
KYTHERA BIOPHARMACEUTICALS INC | Direttore Tecnico/Scientifico/R&S | 01/06/2016 |
University of Southern California
![]() University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
ARCUTIS BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Frank Pompilio
University of Southern California | Doctorate Degree |
University of California, Santa Barbara | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
MANNKIND CORPORATION | Health Technology |
Aziende private | 1 |
---|---|
Kythera Biopharmaceuticals LLC
![]() Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
- Borsa valori
- Insiders
- Frank Pompilio